Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma

Digestive Diseases and Sciences

Volumn 55, Issue 9, 2010, Pages 2545-2551

  Zhang, Hongwei ^a   Li, Mengbin ^a   Han, Yu ^a   Hong, Liu ^a   Gong, Taiqian ^a   Sun, Li ^a   Zheng, Xiushan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Esophageal squamous cell carcinoma; MiR 27a; Multidrug resistance

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; GLYCOPROTEIN P; MICRORNA; MICRORNA 27A; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; VINCRISTINE;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; ESOPHAGEAL NEOPLASMS; FLUOROURACIL; HUMANS; INHIBITORY CONCENTRATION 50; MICRORNAS; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS C-BCL-2; TRANSFECTION; VINCRISTINE;

EID: 77956183846     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-009-1051-6     Document Type: Article

References (18)

1. S Yan C Zhou X Lou, et al. 2009 PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma Cancer Res 69 3283 3290 10.1158/0008-5472.CAN-08-0367 1:CAS:528:DC%2BD1MXksV2hsL8%3D 19351864
2. J Winter S Jung S Keller, et al. 2009 Many roads to maturity: MicroRNA biogenesis pathways and their regulation Nat Cell Biol 11 228 234 10.1038/ncb0309-228 1:CAS:528:DC%2BD1MXisVOltrg%3D 19255566
3. U Lakshmipathy RP Hart 2008 Concise review: MicroRNA expression in multipotent mesenchymal stromal cells Stem Cells 26 356 363 10.1634/stemcells. 2007-0625 1:CAS:528:DC%2BD1cXjt1Wmu7g%3D 17991914 (Pubitemid 351413595)
4. WC Tsai PW Hsu TC Lai, et al. 2009 MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma Hepatology 49 1571 1582 10.1002/hep.22806 1:CAS:528:DC%2BD1MXlslKmurY%3D 19296470
5. KR Cordes D Srivastava 2009 MicroRNA regulation of cardiovascular development Circ Res 104 724 732 10.1161/CIRCRESAHA.108.192872 1:CAS:528:DC%2BD1MXjt1Khtbo%3D 19325160
6. Y Chen RL Stallings 2007 Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis Cancer Res 67 976 983 10.1158/0008-5472.CAN-06-3667 1:CAS:528: DC%2BD2sXht1yntbk%3D 17283129
7. GA Calin M Ferracin A Cimmino, et al. 2005 A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia N Engl J Med 353 1793 1801 10.1056/NEJMoa050995 1:CAS:528:DC%2BD2MXhtFKrtLbJ 16251535 (Pubitemid 41549891)
8. L Hong Y Piao Y Han, et al. 2005 Zinc ribbon domain-containing 1 (ZNRD1) mediates multidrug resistance of leukemia cells through regulation of P-glycoprotein and Bcl-2 Mol Cancer Ther 4 1936 1942 10.1158/1535-7163.MCT-05- 0182 1:CAS:528:DC%2BD2MXhtlCnsrvL 16373708 (Pubitemid 43056976)
9. L Hong T Qiao Y Han, et al. 2006 ZNRD1 mediates resistance of gastric cancer cells to methotrexate by regulation of IMPDH2 and Bcl-2 Biochem Cell Biol 84 199 206 10.1139/O05-173 1:CAS:528:DC%2BD28Xls1ShtL4%3D 16609701 (Pubitemid 43946031)
10. M Fogel P Gutwein S Mechtersheimer, et al. 2003 L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas Lancet 362 869 875 10.1016/S0140-6736(03)14342-5 1:CAS:528: DC%2BD3sXnt1alsbs%3D 13678974 (Pubitemid 37130096)
11. J Ji J Zhang G Huang, et al. 2009 Over-expressed microRNA-27a and 27b influence fat accumulation and cell proliferation during rat hepatic stellate cell activation FEBS Lett 583 759 766 10.1016/j.febslet.2009.01.034 1:CAS:528:DC%2BD1MXitFSls70%3D 19185571
12. O Ben-Ami N Pencovich J Lotem, et al. 2009 A regulatory interplay between miR-27a and Runx1 during megakaryopoiesis Proc Natl Acad Sci USA 106 238 243 10.1073/pnas.0811466106 1:CAS:528:DC%2BD1MXltF2ktw%3D%3D 19114653
13. T Liu H Tang Y Lang, et al. 2009 MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin Cancer Lett 273 233 242 10.1016/j.canlet.2008.08.003 1:CAS:528:DC%2BD1cXhsV2gtbrF 18789835
14. T Arisawa T Tahara T Shibata, et al. 2007 A polymorphism of microRNA 27a genome region is associated with the development of gastric mucosal atrophy in Japanese male subjects Dig Dis Sci 52 1691 1697 10.1007/s10620-006-9648-5 1:CAS:528:DC%2BD2sXotlWitr8%3D 17546506 (Pubitemid 46870565)
15. L Hong J Wang Y Han, et al. 2007 Reversal of multidrug resistance of vincristine-resistant gastric adenocarcinoma cells through up-regulation of DARPP-32 Cell Biol Int 31 9 1010 1015 10.1016/j.cellbi.2007.03.020 1:CAS:528:DC%2BD2sXmtVKisbc%3D 17470401 (Pubitemid 46819074)
16. MH Kang CP Reynolds 2009 Bcl-2 inhibitors: Targeting mitochondrial apoptotic pathways in cancer therapy Clin Cancer Res 15 4 1126 1132 10.1158/1078-0432.CCR-08-0144 1:CAS:528:DC%2BD1MXitVOksLg%3D 19228717
17. G Del Poeta A Bruno MI Del Principe, et al. 2008 Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia Curr Cancer Drug Targets 8 3 207 222 10.2174/156800908784293640 1:CAS:528:DC%2BD1cXmtFamt7Y%3D 18473734 (Pubitemid 351666857)
18. T Asakura K Ohkawa 2004 Chemotherapeutic agents that induce mitochondrial apoptosis Curr Cancer Drug Targets 4 7 577 590 10.2174/1568009043332772 1:CAS:528:DC%2BD2cXhtVWitbfK 15578915 (Pubitemid 39536378)